LOCALLY ADVANCED OR METASTATIC CASTRATION-RESISTANT PROSTATE CANCER

Clinical trials for LOCALLY ADVANCED OR METASTATIC CASTRATION-RESISTANT PROSTATE CANCER explained in plain language.

Never miss a new study

Get alerted when new LOCALLY ADVANCED OR METASTATIC CASTRATION-RESISTANT PROSTATE CANCER trials appear

Sign up with your email to follow new studies for LOCALLY ADVANCED OR METASTATIC CASTRATION-RESISTANT PROSTATE CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Trials to join now! 1

New hope for tough cancers: pfizer tests novel drug combo

Disease control Recruiting now

This study is testing a new drug, PF-07248144, to see if it is safe and can help control advanced cancers that have spread. It will be given to about 320 people with advanced breast, prostate, or lung cancer, both by itself and combined with other cancer drugs. The main goals are…

Matched conditions: LOCALLY ADVANCED OR METASTATIC CASTRATION-RESISTANT PROSTATE CANCER

Phase: PHASE2 • Sponsor: Pfizer • Aim: Disease control

Last updated Apr 03, 2026 14:43 UTC

LOCALLY ADVANCED OR METASTATIC CASTRATION-RESISTANT PROSTATE CANCER

Get alerted when new LOCALLY ADVANCED OR METASTATIC CASTRATION-RESISTANT PROSTATE CANCER trials appear

New hope for tough cancers: pfizer tests novel drug combo